Chen, R., Palmer, J. M., Tsai, N., Thomas, S. H., Siddiqi, T., Popplewell, L., . . . Forman, S. J. (2014). Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphoma.

Chen, Robert, Joycelynne M. Palmer, Ni-Chun Tsai, Sandra H. Thomas, Tanya Siddiqi, Leslie Popplewell, Len Farol, Auayporn Nademanee, ja Stephen J. Forman. Brentuximab Vedotin Is Associated With Improved Progression-free Survival After Allogeneic Transplantation for Hodgkin Lymphoma. 2014.

Chen, Robert, et al. Brentuximab Vedotin Is Associated With Improved Progression-free Survival After Allogeneic Transplantation for Hodgkin Lymphoma. 2014.